INCLUSION BODY MYOSITIS
Clinical trials for INCLUSION BODY MYOSITIS explained in plain language.
Never miss a new study
Get alerted when new INCLUSION BODY MYOSITIS trials appear
Sign up with your email to follow new studies for INCLUSION BODY MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for rare muscle disease
Disease control CompletedThis study tested a new drug, ABC008, in 272 adults with inclusion body myositis, a rare muscle-weakening disease. The goal was to see if the drug is safe and can slow the disease's progression. Participants received either the drug or a placebo, and researchers measured muscle f…
Matched conditions: INCLUSION BODY MYOSITIS
Phase: PHASE2, PHASE3 • Sponsor: Abcuro, Inc. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Stem cells injected into muscles in rare disease safety trial
Symptom relief CompletedThis study tested whether stem cells taken from a person's own fat and injected into their forearm and thigh muscles are safe for people with Inclusion Body Myositis, a rare muscle-weakening disease. Nine adults took part, each receiving injections on one side of the body. The ma…
Matched conditions: INCLUSION BODY MYOSITIS
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Symptom relief
Last updated May 26, 2026 05:51 UTC
-
Military myositis mystery: researchers hunt for environmental triggers
Knowledge-focused CompletedThis study looked at why some military personnel develop myositis, a rare disease where the immune system attacks muscles, causing weakness and pain. Researchers compared 37 people with and without myositis, using questionnaires and blood samples to find possible environmental tr…
Matched conditions: INCLUSION BODY MYOSITIS
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC